Found: 82
Select item for more details and to access through your institution.
Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1510, doi. 10.3390/cancers16081510
- By:
- Publication type:
- Article
Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 886, doi. 10.3390/cancers16050886
- By:
- Publication type:
- Article
Tracing the Evolution of Prostate Brachytherapy in the 20th Century.
- Published in:
- Oncology, 2024, v. 102, n. 3, p. 283, doi. 10.1159/000534017
- By:
- Publication type:
- Article
Interventional Radiotherapy in Gynecological Cancer.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3516, doi. 10.3390/cancers15133516
- By:
- Publication type:
- Article
Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2784, doi. 10.3390/cancers15102784
- By:
- Publication type:
- Article
Optimization of Radium-223 Treatment of Castration-resistant Prostate Cancer Based on the Burden of Skeletal Metastasis and Clinical Parameters.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 246, doi. 10.1093/oncolo/oyac245
- By:
- Publication type:
- Article
Change of the Neutrophil-to-Lymphocyte Ratio during Treatment: A Potential Prognostic Biomarker in Metastatic Prostate Cancer Treated with Radium-223 Dichloride.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4606, doi. 10.3390/cancers14194606
- By:
- Publication type:
- Article
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1006, doi. 10.1002/onco.13949
- By:
- Publication type:
- Article
Error in Key Points.
- Published in:
- 2021
- Publication type:
- Correction Notice
Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2114694, doi. 10.1001/jamanetworkopen.2021.14694
- By:
- Publication type:
- Article
Radium Ra 223 Alpha Therapy for Prostate Cancer Bone Metastasis.
- Published in:
- Radiologic Technology, 2021, v. 92, n. 6, p. 618
- By:
- Publication type:
- Article
The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3213, doi. 10.3390/cancers12113213
- By:
- Publication type:
- Article
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 31, doi. 10.3390/cancers12010031
- By:
- Publication type:
- Article
Oncology Drug Reference Sheet: Radium 223 Dichloride (Xofigo®).
- Published in:
- ONS Voice, 2019, v. 34, n. 12, p. 21
- By:
- Publication type:
- Article
Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases.
- Published in:
- American Health & Drug Benefits, 2019, v. 12, n. 3, p. 142
- By:
- Publication type:
- Article
Radium-223 therapy in Metastatic Castration-Resistant Prostate Cancer: effects on tumor and normal cell lines.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Is interim <sup>18</sup>F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?
- Published in:
- Radiologia Brasileira, 2019, v. 52, n. 1, p. 33, doi. 10.1590/0100-3984.2017.0178
- By:
- Publication type:
- Article
Novel Insights on the Current and Emerging Treatment Strategies of CRPC.
- Published in:
- Journal of Managed Care Medicine, 2018, v. 21, n. 4, p. 33
- By:
- Publication type:
- Article
Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 822, doi. 10.1007/s00259-017-3913-z
- By:
- Publication type:
- Article
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 824, doi. 10.1007/s00259-017-3900-4
- By:
- Publication type:
- Article
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.
- Published in:
- Oncology, 2018, v. 94, n. 3, p. 161, doi. 10.1159/000485102
- By:
- Publication type:
- Article
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 173, doi. 10.1007/s10147-017-1176-0
- By:
- Publication type:
- Article
Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.
- Published in:
- Oncologist, 2018, v. 23, n. 2, p. 193, doi. 10.1634/theoncologist.2017-0413
- By:
- Publication type:
- Article
Ra-223 SPECT for semi-quantitative analysis in comparison with Tc-99m HMDP SPECT: phantom study and initial clinical experience.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0330-z
- By:
- Publication type:
- Article
A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion.
- Published in:
- Canadian Urological Association Journal, 2017, v. 11, n. 10, p. 350, doi. 10.5489/cuaj.4415
- By:
- Publication type:
- Article
Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 954, doi. 10.1007/s10147-017-1130-1
- By:
- Publication type:
- Article
Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice.
- Published in:
- Reviews in Urology, 2017, v. 19, n. 4, p. 248, doi. 10.3909/riu0782
- By:
- Publication type:
- Article
An Important Document for the History of Turkish Radiation Oncology: "The Principles of Radium Treatment".
- Published in:
- Journal of History, Culture & Art Research / Tarih Kültür ve Sanat Arastirmalari Dergisi, 2017, v. 6, n. 4, p. 40, doi. 10.7596/taksad.v6i4.836
- By:
- Publication type:
- Article
Prostate and lung cancer: NICE recommends new treatments and better access.
- Published in:
- Nurse Prescribing, 2016, v. 14, n. 11, p. 526, doi. 10.12968/npre.2016.14.11.526
- By:
- Publication type:
- Article
Radioisotopes in management of metastatic prostate cancer.
- Published in:
- Indian Journal of Urology, 2016, v. 32, n. 4, p. 277, doi. 10.4103/0970-1591.189708
- By:
- Publication type:
- Article
Geoffrey Keynes's Two-Fold Vision: Medical Savant-Connoisseur and Literary Bibliographer.
- Published in:
- Journal of the History of Medicine & Allied Sciences, 2016, v. 71, n. 4, p. 377, doi. 10.1093/jhmas/jrw006
- By:
- Publication type:
- Article
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation.
- Published in:
- International Journal of Molecular Imaging, 2016, p. 1, doi. 10.1155/2016/2568031
- By:
- Publication type:
- Article
Radium Ra 223 Dichloride Therapy in the Private Practice Environment.
- Published in:
- Reviews in Urology, 2016, v. 18, n. 2, p. 106, doi. 10.3909/riu0720
- By:
- Publication type:
- Article
Experimenting with Radium Therapy: In the Laboratory & the Clinic.
- Published in:
- Clio Medica, 2016, v. 95, n. 1, p. 194, doi. 10.1163/9789004286719_009
- By:
- Publication type:
- Article
Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospect... [including commentary by SHI-MING TU, MEHMET ASIM BILEN, and SUE-HWA LIN].
- Published in:
- Oncology (08909091), 2015, v. 29, n. 7, p. 483
- By:
- Publication type:
- Article
Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Multidisciplinary Healthcare, 2015, v. 8, p. 279, doi. 10.2147/JMDH.S81007
- By:
- Publication type:
- Article
Radium-223 for the treatment of castration-resistant prostate cancer.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 1103, doi. 10.2147/OTT.S44291
- By:
- Publication type:
- Article
Update on Ra-223 Therapy after FDA Approval.
- Published in:
- AUANews, 2015, v. 20, n. 4, p. 16
- By:
- Publication type:
- Article
Nursing Management of Patients With Castration-Resistant Prostate Cancer Undergoing Radium-223 Dichloride Treatment.
- Published in:
- Clinical Journal of Oncology Nursing, 2015, v. 19, n. 2, p. E31, doi. 10.1188/15.CJON.E31-E35
- By:
- Publication type:
- Article
Radium-223 Dichloride (Ra-223) for the Treatment of Metastatic Castration-resistant Prostate Cancer: Optimizing Clinical Practice in Nuclear Medicine Centers.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 1, doi. 10.13032/tjop.2052-5931.100121
- By:
- Publication type:
- Article
Dosimetric study of radium-223 chloride and Sm-EDTMP for treatment of bone metastases using MCNPX code and available experimental data.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2015, v. 303, n. 3, p. 1991, doi. 10.1007/s10967-014-3641-9
- By:
- Publication type:
- Article
Radium-223: Role of Bone Metastases in Castration-Resistant Prostate Cancer.
- Published in:
- Cancer & Chemotherapy Reviews, 2015, v. 10, n. 1, p. 3
- By:
- Publication type:
- Article
Clival Keloid After Nasopharyngeal Radium Irradiation Masquerading as Skull Base Malignancy.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Radium-223 vs EBRT for Multiple Painful Bone Metastases: The Data Favor Radium-223.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 296
- By:
- Publication type:
- Article
Radium-223 vs EBRT for Multiple Painful Bone Metastases: Is Less More?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 297
- By:
- Publication type:
- Article
Palliative RT Research in Prostate Cancer: Understanding the Past, Anticipating the Future.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 313
- By:
- Publication type:
- Article
A new agent in therapeutic armamentarium of survival enhancing drugs in castrate resistant prostate cancer.
- Published in:
- Indian Journal of Urology, 2014, v. 30, n. 1, p. 122
- Publication type:
- Article
Advances in prostate cancer treatment.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 11, p. 823, doi. 10.1038/nrd4068
- By:
- Publication type:
- Article
Sequencing of Agents for Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 11, p. 1144
- By:
- Publication type:
- Article